SCHEMBL10176552

SCHEMBL10176552

Cc1cc(OCCN2CCOCC2)ccc1/N=C1/NC(=O)/C(=C/c2cnc(N3CCCCC3)s2)S1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.47
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALOX5 P09917 1/20 0.41
KDR P35968 1/20 0.41
NPC1 O15118 2/20 0.41
MAPT P10636 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RECQL P46063 1/20 0.39
HRH3 Q9Y5N1 2/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAOA P21397 1/20 0.37
POLB P06746 1/20 0.37
FLT3 P36888 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL649313 1.00 HPGD (0.47) HPGDMEN1KMT2AALOX5KDR
SCHEMBL10176549 0.86 MAPT (0.41) HPGDMEN1KMT2AMAPTNPSR1
SCHEMBL650960 0.86 MAPT (0.41) HPGDMEN1KMT2AMAPTNPSR1
SCHEMBL10176546 0.85 HPGD (0.48) HPGDMEN1KMT2AMAPTNPSR1
SCHEMBL652913 0.84 HPGD (0.46) HPGDMEN1KMT2AALOX5KDR
SCHEMBL652914 0.84 HPGD (0.46) HPGDMEN1KMT2AALOX5KDR
SCHEMBL649312 0.83 HPGD (0.43) HPGDMEN1KMT2AALOX5KDR
SCHEMBL649314 0.83 HPGD (0.43) HPGDMEN1KMT2AALOX5KDR
SCHEMBL10176445 0.82 HPGD (0.44) HPGDMEN1KMT2AALOX5KDR
SCHEMBL649545 0.82 HPGD (0.44) HPGDMEN1KMT2AALOX5KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 HPGD 3970/4885MEN1 1406/4885KMT2A 3437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.